Prodromal Parkinson’s Disease in Agent Orange Exposed US Vietnam Veterans
Objective: 1-Comparing the risk of prodromal PD between AO exposed veterans (AOEV) and non-AO exposed veterans without PD (Controls) in a Veterans Affairs (VA) hospital…Multidisciplinary Approaches to Palliative Care in Late-Stage Parkinson’s Disease: A Review of Educational Tools and Frameworks
Objective: To evaluate multidisciplinary approaches to palliative care in late-stage Parkinson’s disease (PD) and assess the effectiveness of educational tools and frameworks in improving patient…Family History of Parkinson’s Disease in Patients with Essential Tremor and in Patients with Parkinson’s Disease and Its Association with Different Phenotypes.
Objective: To clinically and phenotypically describe essential tremor (ET) and parkinson's disease (PD) patients and compare their familial histories in first- and second-degree relatives.. Background:…Risk factors in a population with high prevalence of Parkinson’s disease in Chile
Objective: The aim of this study was to investigate the frequency of environmental risk factors, comorbidities and family history in a population with Pakinson disease…Perceived Versus Actual Performance During Dual-Task Walking: Insights from Parkinson’s Disease
Objective: To explore the concordance between perceived difficulty and focus, to actual performance during a dual-task (DT) two-minute walk test (2MWT) in people with Parkinson’s…Association Between Depression and Sleep Disorders in Parkinson’s Disease
Objective: To investigate the clinical characteristics of depression in Parkinson’s disease (PD) and its correlation with sleep disorders. Background: PD is the second most common…Neuronal DJ-1 regulates microglia activation via ADAM10-mediated CX3CL1 secretion
Objective: DJ-1, also known as Parkinson's disease protein 7 (PARK7), is a multifunctional protein that is important in regulating oxidative stress and neuroprotection. Background: The…Longitudinal Brain Morphometric Trajectories Across Parkinson Disease Clinical Subtypes
Objective: To investigate longitudinal brain morphometric trajectories across Parkinson disease (PD) clinical subtypes Background: We developed a PD multi-domain classification based on motor and non-motor…Contribution of Dopamine Depletion, Cerebral Perfusion, and Cognition to Gait Dysfunction in Parkinson’s Disease
Objective: To explore the potential contribution of dopamine loss, perfusion deficit, and cognition to spatiotemporal gait parameters in patients with Parkinson's disease (PD). Background: Gait…Comparison of Microglial PET Imaging in Parkinson’s Disease, RBD, and Controls with a CSF1R and TSPO Ligand.
Objective: To compare regional binding patterns of microglial PET radioligands: [11C]DPA-713, a TSPO ligand, and [11C]CPPC1, a CSF1R ligand in people with Parkinson’s disease (PD).…
- « Previous Page
- 1
- …
- 27
- 28
- 29
- 30
- 31
- …
- 436
- Next Page »
